Introduction

Anhydrous Dibasic Calcium Phosphate (DCPA) is a widely used pharmaceutical excipient in oral solid dosage formulations. Its chemical stability, low hygroscopicity, and functional powder properties make it a valuable choice for pharmaceutical manufacturers.

However, different DCPA grades can exhibit significantly different particle size distributions, flowability, bulk density, and compression behavior. These differences directly influence their suitability for specific manufacturing processes.

At Westpoint Pharma, our DESU^® DCPA Crystalline Series includes three differentiated grades: DESU^® DCPA 12 II, DESU^® DCPA 60 II, and DESU^® DCPA 150 II.

Through controlled particle size distribution and differentiated powder properties, Westpoint Excipients provides flexible DCPA solutions for wet granulation, dry granulation, direct compression, and high-hardness tablet formulations.

Understanding the differences between these three grades helps formulation scientists select the most suitable pharmaceutical excipient for their specific manufacturing requirements.

---

1. How Do the Particle Sizes of Different DCPA Grades Compare?

Particle size is a key factor influencing powder flowability, packing behavior, and tablet compression performance.

Although all three DESU^® DCPA crystalline grades share a similar agglomerated particle structure with relatively rough surfaces, their particle size distributions differ considerably.

DESU^® DCPA 12 II – Fine Particle Grade

DESU^® DCPA 12 II is the finest grade in our crystalline DCPA portfolio.

Its fine particle size provides a relatively high number of particle contact points. However, the smaller particles also exhibit stronger interparticle interactions, which can affect powder flowability.

This grade is particularly suitable for wet granulation, where fine particles facilitate binder distribution and wetting during the granulation process.

DESU^® DCPA 60 II – Medium Particle Grade

DESU^® DCPA 60 II features a medium particle size and a relatively concentrated particle size distribution.

Its balanced particle size and favorable flow properties make it a suitable choice for direct compression.

Among the three crystalline grades, DESU^® DCPA 60 II combines the highest bulk density with excellent powder flowability, making it particularly useful for high-speed tablet manufacturing.

DESU^® DCPA 150 II – Coarse Particle Grade

DESU^® DCPA 150 II is the coarsest grade in the crystalline series.

Its larger particles feature more pronounced surface irregularities and a higher BET surface area than the other crystalline grades.

During compression, these rough surfaces provide more opportunities for mechanical interlocking between particles, contributing to stronger tablet formation.

DESU^® DCPA 150 II is particularly suitable for high-hardness tablets and formulations requiring specific coarse-particle characteristics.

---

2. What Are the Differences in Powder Properties?

Particle size distribution influences several important powder properties, including flowability, bulk density, and water absorption.

The following comparison highlights the functional differences among the three DESU^® DCPA grades.

2.1 How Does Flowability Differ?

The angle of repose is an important indicator of powder flowability and can influence feeding consistency and tablet weight variation during high-speed compression.

The three grades demonstrate distinct flow characteristics:

For pharmaceutical manufacturers prioritizing powder feeding consistency in direct compression, DESU^® DCPA 60 II and 150 II are suitable candidates for evaluation.

2.2 How Does Bulk Density Affect Formulation Design?

Bulk density directly influences powder filling, tablet volume, and formulation space requirements.

Among the three crystalline grades, DESU^® DCPA 60 II has the highest bulk density, approximately 1.17 g/mL.

This high density allows more excipient mass to be accommodated within the same die volume, making it particularly useful for formulations requiring high-density filling and controlled tablet dimensions.

The other two grades demonstrate different packing characteristics:

Therefore, DESU^® DCPA 60 II is a suitable option when formulation volume and filling density are important considerations.

2.3 What Is the Difference in Water Absorption and pH?

Water absorption and suspension pH are also important considerations when selecting DCPA for formulations containing sensitive APIs.

Water Absorption

DESU^® DCPA 12 II and 60 II have relatively low water absorption values of approximately 48–50%.

In comparison, DESU^® DCPA 150 II has a significantly higher water absorption value of approximately 92%, associated with its rougher surface structure and capillary characteristics.

For moisture-sensitive formulations, the lower water absorption of DESU^® DCPA 12 II and 60 II may be advantageous during excipient selection.

Suspension pH

DESU^® DCPA 12 II and 60 II exhibit approximately neutral pH characteristics, while DESU^® DCPA 150 II has a relatively acidic suspension pH of approximately 5.11.

This difference is worth considering when developing formulations containing alkali-sensitive APIs, where the microenvironment created by excipients may influence drug stability.

---

3. How Do the Three DCPA Grades Perform During Tablet Compression?

Compressibility is another important parameter when evaluating DCPA for pharmaceutical tablet manufacturing.

Although all three grades belong to the crystalline DCPA series, their particle size and surface characteristics lead to different compression behaviors.

Under the reported compression condition of 30 kN, the three grades demonstrate the following tablet hardness results.

DESU^® DCPA 150 II – Highest Compressibility

DESU^® DCPA 150 II achieves tablet hardness of approximately 350 N at 30 kN, demonstrating the best compressibility among the three crystalline grades.

Its relatively coarse particles and rough surface structure provide multiple mechanical interlocking points during compression.

These interactions help transfer compression forces between particles and form a dense tablet structure.

This makes DESU^® DCPA 150 II particularly suitable for high-hardness tablets and formulations requiring strong mechanical integrity.

DESU^® DCPA 12 II – Moderate Compressibility

DESU^® DCPA 12 II achieves tablet hardness of approximately 278 N at 30 kN.

Although its fine particles provide numerous contact points, the brittle fracture characteristics of crystalline DCPA can limit deformation coordination under higher compression forces.

Nevertheless, its compressibility is better than that of DESU^® DCPA 60 II.

During wet granulation, particle growth can further improve its granule formation and compression behavior.

DESU^® DCPA 60 II – Relatively Lower Compressibility

DESU^® DCPA 60 II achieves tablet hardness of approximately 220 N at 30 kN.

Its relatively high bulk density means that the particles are already closely packed before compression, leaving less space for further particle rearrangement.

Additionally, its medium particle size provides less pronounced mechanical interlocking than DESU^® DCPA 150 II.

Consequently, its tablet hardness development is relatively limited compared with the other two crystalline grades.

However, tablets produced with DESU^® DCPA 60 II generally demonstrate favorable surface smoothness.

Tablet Compression Performance Comparison

The results demonstrate that particle size and surface structure play important roles in determining the compression behavior of crystalline DCPA.

---

4. Which DCPA Grade Is Best for Different Formulation Applications?

Selecting the appropriate DCPA grade requires consideration of API properties, manufacturing processes, and the desired tablet characteristics.

At Westpoint Pharma, we recommend evaluating the three DESU^® DCPA crystalline grades according to their differentiated functional properties.

4.1 DESU^® DCPA 12 II – Wet Granulation and Dry Granulation

DESU^® DCPA 12 II is particularly suitable for wet granulation because of its fine particle size and relatively low water absorption.

Its fine particles facilitate uniform binder distribution and wetting, supporting the formation of dense granules with suitable mechanical strength.

Although its original powder flowability is moderate, granulation increases particle size and can improve subsequent processing performance.

DESU^® DCPA 12 II can also be incorporated into dry granulation formulations, where its moderate compressibility contributes to roller compaction and granule formation.

For moisture-sensitive APIs, its relatively low water absorption compared with DESU^® DCPA 150 II is another consideration during formulation development.

4.2 DESU^® DCPA 60 II – Direct Compression

DESU^® DCPA 60 II is a suitable grade for conventional direct compression.

Its combination of excellent flowability and high bulk density supports:

These characteristics make DESU^® DCPA 60 II particularly useful for large-scale commercial tablet manufacturing.

Lubricant Sensitivity Consideration

When using DESU^® DCPA 60 II, magnesium stearate concentration should be carefully controlled.

A recommended magnesium stearate concentration is below 1% to reduce the risk of over-lubrication and the associated decrease in tablet hardness.

4.3 DESU^® DCPA 150 II – High-Hardness Tablets and Specialized Formulations

DESU^® DCPA 150 II offers the highest compressibility among the three crystalline grades, together with higher water absorption and relatively acidic suspension pH.

These characteristics make it suitable for several specialized applications.

High-Hardness Tablets and Sustained-Release Matrix Tablets

For formulations requiring high mechanical strength and resistance to tablet breakage, DESU^® DCPA 150 II offers an advantage through its particle interlocking characteristics.

Liquid and Oily API Adsorption

Although spray-dried DCPA generally provides better liquid adsorption performance, DESU^® DCPA 150 II can also contribute to the adsorption and solidification of limited quantities of liquid or oily APIs.

Its rough surface and relatively high water absorption provide additional formulation possibilities, while its compression performance supports tablet hardness.

Alkali-Sensitive APIs

Its relatively acidic suspension pH of approximately 5.11 may provide a more suitable microenvironment when evaluating formulations containing certain alkali-sensitive APIs.

Formulations Containing Large API Particles

When an API has a relatively large particle size, DESU^® DCPA 150 II can be considered for adjusting the particle size distribution of the powder blend.

This may help optimize particle size compatibility and reduce segregation risks associated with differences in particle size.

Application Selection Summary

---

Conclusion

Although DESU^® DCPA 12 II, 60 II, and 150 II all belong to the crystalline anhydrous dibasic calcium phosphate family, their differentiated particle size distributions create distinct functional advantages.

At Westpoint Pharma, we develop differentiated pharmaceutical excipients through controlled particle engineering and functional performance evaluation.

Our DESU^® DCPA Crystalline Series enables pharmaceutical manufacturers to select suitable excipient grades according to their formulation requirements, processing conditions, and target tablet performance.

Through Westpoint Pharma and Westpoint Excipients, we are committed to providing reliable pharmaceutical excipient solutions and technical support for formulation development worldwide.

Explore our pharmaceutical excipient portfolio at www.westpointexcipients.com.